<DOC>
	<DOCNO>NCT01977755</DOCNO>
	<brief_summary>This study explore potential cardioprotective property danegaptide administer patient ST-Segment elevation myocardial infarction .</brief_summary>
	<brief_title>Phase 2 Clinical Proof-of-Concept Study Cardioprotective Properties Danegaptide ST Segment Elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Age â‰¥ 18 year STsegment elevation myocardial infarction Acute onset chest pain &lt; 12 hour duration Pregnancy Known prior Myocardial Infarction area present STEMI , know hypertrophic dilate cardiomyopathy , prior hospital admission heart failure Contraindication cardiac MRI Inability understand information provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>